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MRIAbstract Aim: To determine if focal liver masses could be differentiated as benign or malignant
by DWI and ADC maps.
Methods and materials: Sixty focal liver lesions were scanned using 1.5 T MRI. DWI was per-
formed with b 0, b 500 and b 1000 gradients with ADC measurements. Comparison of mean
ADC values between each benign and malignant lesion was done. Reference standard of diagnosis
was obtained by correlating DWI with histopathologic ﬁndings and imaging follow-up. The accu-
racies of DWI and ADC values were assessed with the Student’s t test, and cut-off values were
determined with receiver operating characteristic curve analysis.
Results: When ADC value of 1.0 · 103 mm2/s was used as a threshold value for differentiation of
malignant tumors from benign lesions, sensitivity was 90.3%, speciﬁcity 78.57% and accuracy
86.7%. The best result was obtained with the use of ADC cut off value (at b 500) of
1.5 · 103 mm2/s and ADC cut off value (at b 1000) of 1.0 · 103 mm2/s, with 90.3% sensitivity,
92.86% speciﬁcity, 91.1% accuracy, 96.6% positive predictive value and 81.3% negative predictive
value.
Conclusion: DWI and ADC map is a useful tool in differential diagnosis of malignant from benign
liver lesions.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.receiver
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The differential diagnosis between malignant and benign focal
liver lesions remains a diagnostic challenge for every radiolo-
gist. For detection and characterization of focal liver lesions,
many different modalities have been proposed; including mul-
ti-phase contrast-enhanced CT (1), MRI (2), CT portography
(3) and perfusion studies using dedicated ultrasound or CT or
MRI contrast agents (4). Of these modalities, magnetic reso-
nance imaging is considered the most accurate imaging tech-
nology because it has high resolution for soft tissue and has
the potential to characterize a lesion on various data acquired,
such as T1, T2, and early and late post-gadolinium images
(5,6).
Magnetic resonance imaging (MRI) has been used in both
the detection and characterization of focal hepatic lesions.
With the advent of the echo-planar MR imaging technique,
diffusion weighted imaging (DWI) of the abdomen has become
possible with fast imaging times which minimize the effect of
gross physiologic motion from respiration and cardiac move-
ment (7). Thus, DWI became a valuable technique for evaluat-
ing focal hepatic lesions in addition to conventional MRI
sequences (8). More recently, apparent diffusion coefﬁcient
(ADC) value has been introduced in quantitative measure-
ments as an adjunct to DWMRI. ADC is a quantitative
parameter measuring the rate of diffusion of water molecules
in biological tissues. There are several reports regarding the
use of ADC in diagnosis and characterization of focal hepatic
lesions (7–10). However, the efﬁcacy of ADC values in diag-
nosing and characterization of solid benign and solid malig-
nant lesions has not been well described. Similarly, lesion
and diffusion gradient variabilities were also limited in these
studies (8–10). Usage of ADC measurements in various types
of focal hepatic lesions at different diffusion gradient values
may deﬁne the role of ADC values in radiological evaluation
of focal hepatic lesions (11).
The expanding role of DWI in evaluation of liver lesions
can increase conﬁdence in differentiation between benign and
malignant lesions. DW sequences can be performed on most
modern MRI machines with relative ease, in a short time per-
iod and without the need for contrast medium (12).
2. Patients and methods
2.1. Patients
Between June 2011 and December 2012, a total of 60 focal he-
patic lesions in 60 consecutive patients were evaluated by
abdominal MRI with informed consent was taken from them.
Patients with hepatic neoplasms who had undergone chemo-
therapy or radiation therapy within the last 3 months prior
to the MR examination were excluded from our analysis in or-
der to ensure that ADC measurements were reﬂective of the
natural state of the liver lesions. In addition, patients without
sufﬁcient conﬁrmation of the nature of the lesions were ex-
cluded. The ﬁnal study population consisted of 60 patients
(43 men, 17 women; age range 20–70 years, mean age
45 years).
There were 9 patients with history of an extra-hepatic pri-
mary malignancy and suspected liver metastases (colorectal
cancer [n= 3], breast cancer [n= 2], gastric cancer [n= 1],and pancreatic cancer [n= 3]). There were 28 patients with
chronic liver disease (including chronic hepatitis and cirrhosis
related to hepatitis C and old bilharziasis) with suspected
malignancy. Finally, there were 23 patients with no history
of malignancy or chronic liver disease who underwent MR
imaging for evaluation of presumably benign or indeterminate,
incidentally diagnosed focal liver lesions (FLL). In patients
with multiple FLL, the largest ones of each lesion type were
randomly selected for further analysis by the study
coordinator.
Thirty-four lesions were malignant tumors (20 hepatocellu-
lar carcinomas (HCCs), 5 cholangiocarcinomas and 9 metasta-
ses). Benign liver lesions were 26 (8 cysts, 8 hemangiomas, 5
adenomas and 5 focal nodular hyperplesia (FNH).
The standard of reference for characterizing FLL was eval-
uated by two radiologists (GE & MA), with experience in MR
imaging of 20 and 10 years respectively. Malignant nature of
lesions was conﬁrmed by pathologic ﬁndings following biopsy
or surgery for 13 HCCs, 5 cholangiocarcinomas and 5 metas-
tases. The diagnosis of the remaining 7 HCCs lesions was con-
ﬁrmed by using the established imaging criteria and follow up
after chemoembolization. The remaining 4 metastatic lesions
were conﬁrmed on the basis of new occurrence of a lesion com-
pared to a prior MR study, follow up of lesion size after the
start of chemotherapy in patients with known extra-hepatic
primary malignancies. Three FNHs and 2 adenomas were con-
ﬁrmed pathologically. The remaining benign lesions were diag-
nosed by using established imaging criteria (13–15) in
conjunction with stable appearance and size at follow-up imag-
ing in equivocal cases with a minimum follow-up interval of
6 months (range: 6–12 months).2.2. MR imaging and image analysis
Magnetic resonance imaging examinations were performed on
1.5 T system (Philips, Achieva) with a 16-channel body coil.
Before DWI, breath-hold T1-weighted image, fat-saturated
fast spin echo T2 weighted image, dual echo fast spoiled gradi-
ent-echo (FSPGR) and single shot fast spin echo (SSFSE) T2
weighted images were obtained in axial and coronal images.
Diffusion weighted images were obtained before contrast
administration with b values of 0, 500, and 1000 s/mm2.
Breath-hold, dynamic 3D T1 weighted sequence was per-
formed after DWIs (bolus injection of 20 ml gadopentetate
dimeglumine 1.5 ml/s). All DWIs were obtained in transverse
plane using single-shot echo-planar spin echo sequences. Imag-
ing parameters for DWIs were: TR: 1100 ms; TE: 67–91 ms;
FOV: 35 cm · 35 cm (change according to body size); number
of excitation: 1; matrix size: 128 · 128; section thickness:
5 mm; intersection gap: none. DW sequences required a total
of 96 s to scan on MR. The array spatial sensitivity encoding
technique (ASSET) was used as a parallel imaging technique.
Imaging ﬁndings were evaluated carefully, then, ADC val-
ues of different masses detected on conventional MRI se-
quences and DWI were measured through gray-scale ADC
maps from each lesion at b 500, and b 1000 s/mm2 gradient val-
ues by using 3 circumferential region of interests (ROIs) and
the average ADC values were recorded. ADCs were measured
over the largest mass detected in patients with multiple liver le-
sions. Necrotic portions of solid lesions detected on contrast
enhanced MRI were excluded.
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other benign liver masses) and the malignant lesion group
(HCC, cholangiocarcinoma and metastasis) at 2 different dif-
fusion gradients were compared. Similarly, mean ADC values
of each benign and malignant lesion at 2 different gradients
were also recorded and compared in order to determine
whether it would be possible to deﬁne the characteristic or type
of individual benign and malignant lesion.
To validate our system, ADC values of water were mea-
sured on phantoms one week before the ADC measurements.
The ADC value for water was 2.21 · 103 mm2/s, in agreement
with other studies in the literature (16).
2.3. Statistical analysis
Statistical analysis was carried out via Statistical package for
social Science (SPSS), version 17 program on windows XP.
Qualitative data were represented in the form of number and
frequency, while quantitative data were represented in the
form of mean ± standard deviation (mean ± SD). Kolmo-
grov–Smirnov test was used to test normality of quantitative
data. Student’s t test, Mann–Whitney U and Kruskal–Wallis
test were used to compare groups. Receiver operating charac-
teristic (ROC) curve was computed to determine the cut off va-
lue for the malignancy. All tests were considered signiﬁcant if
P value equals or less than 0.05.3. Results
Mean size of all 60 focal hepatic lesions was 2.83 ± 1.05 cm.
Twenty-six of the 60 lesions were benign and 34 were malig-
nant. Benign lesions had a mean size of 2.96 ± 0.77 cm (rangesTable 1 Mean size, mean ADC values of benign and malignant les
Report
Tumor Mean s
Benign Mean 2.9643
N 26
Std. Deviation .77122
Minimum 2.00
Maximum 5.00
Range 3.00
Median 3.0000
Malignant Mean 2.7774
N 34
Std. Deviation 1.17266
Minimum 1.00
Maximum 6.00
Range 5.00
Median 2.5000
Total Mean 2.8356
N 60
Std. Deviation 1.05876
Minimum 1.00
Maximum 6.00
Range 5.00
Median 2.50002–5 cm) whereas mean size of malignant lesions was
2.77 ± 1.17 cm (ranges 1–6 cm) (Table 1).
Mean ADC values of 26 benign lesions at b 500 and b 1000
gradients were 2.09 ± 0.50 · 103 and 1.55 ± 0.43 ·
103 mm2/s, respectively. Mean ADC values of malignant
lesions at b 500 and b 1000 gradients were 1.20 ±
0.18 · 103 and 0.85 ± 0.18 · 103 mm2/s, respectively. Mean
ADC values of benign lesions were higher than malignant
lesions and these differences were statistically signiﬁcant for
the 2 diffusion gradients (P< 0.0001 & P< 0.0001, respec-
tively) (Table 1).
Mean ADC values of all lesions at b 500 and b 1000 gradi-
ents and differentiation between subtypes of benign and malig-
nant lesions are summarized in Table 2.
An ADC cut-off value of 1.0 · · 103 mm2/s at b 1000 dif-
fusion gradient resulted in 90.3% sensitivity, 78.6% speciﬁcity
and 86.7% accuracy for differentiation of benign and malig-
nant focal hepatic lesion groups. The best result was obtained
with the use of ADC cut off value of 1.5 · 103 mm2/s at b 500
and ADC cut off value of 1.0 · 103 mm2/s at b 1000, with
90.3% sensitivity, 92.86% speciﬁcity, and 91.1% accuracy.
The results of ROC curve analyses, ADC cut off values for
the differentiation between benign and malignant lesions at
both b 500 and b 1000 diffusion gradients are shown in Tables
3 and 4.
Seventeen of the 26 benign lesions show low SI and 9 be-
nign lesions show intermediate SI on DWI while 26 of the 34
malignant lesions show high SI and 8 malignant lesions show
intermediate SI on DWI.
Cysts and hemangiomas showed the highest mean ADC val-
ues at b 500 and b 1000 gradients in the benign lesion group
(Fig. 1). Hepatocellular carcinomas showed highest mean ADC
values at b 500 and b 1000 in the malignant lesion group (Fig. 2).ions at both b 500 and b 1000.
ize ADC b 500 ADC b 1000
2.0929 1.5500
26 26
.50909 .43456
1.30 .80
2.90 2.00
1.60 1.20
2.2000 1.8000
1.2065 .8587
34 34
.18246 .18335
.90 .50
1.80 1.40
.90 .90
1.2000 .8500
1.4822 1.0738
60 60
.52105 .42833
.90 .50
2.90 2.00
2.00 1.50
1.3000 .9000
Table 2 Mean size, mean ADC values and differentiation of different subtypes of benign and malignant lesions.
Report
Tumor Type Mean size ADC b 500 ADC b 1000 P value ADC b 500 ADC b 1000
HCC Mean 3.1250 1.2650 .8925 HCC vs. cholangiocarcinoma 0.014 0.61
N 20 20 20 HCC vs metastasis 0.034 0.27
Std. Deviation 1.22512 .17554 .18806 Cholangiocarcima vs metastasis 0.44 0.51
Minimum 1.50 1.00 .50
Maximum 6.00 1.80 1.40
Range 4.50 .80 .90
Median 2.8500 1.2000 .8900 Adenoma vs HCC <0.001 0.008
Metastases Mean 1.9000 1.1111 .8078 Adenoma vs metastases <0.001 0.014
N 9 9 9 Adenoma vs cholangiocarcinoma <0.001 0.023
Std. Deviation .59372 .16159 .18089 FNH vs HCC <0.001 <0.001
Minimum 1.00 .90 .55 FNH vs metastases <0.001 0.004
Maximum 3.00 1.40 1.20 FNH vs cholangiocarcinoma 0.005 0.015
Range 2.00 .50 .65
Median 2.0000 1.1000 .8000
Cholangiocarcinoma Mean 3.2500 1.0500 .7500
N 5 5 5
Std. Deviation .35355 .07071 .07071
Minimum 3.00 1.00 .70
Maximum 3.50 1.10 .80
Range .50 .10 .10
Median 3.2500 1.0500 .7500
FNH Mean 3.2000 1.8600 1.4600 FNH vs Hemangioma 0.16 0.27
N 5 5 5 FNH vs adenoma 0.98 0.45
Std. Deviation 1.15109 .47223 .51284 FNH vs cysts 0.001 0.05
Minimum 2.00 1.30 .90 Hemangioma vs adenoma 0.22 0.06
Maximum 5.00 2.30 1.90 Hemangioma vs cysts 0.15 0.47
Range 3.00 1.00 1.00 Adenoma vs cysts 0.002 <0.001
Median 3.0000 2.1000 1.8000
Hemangioma Mean 2.7500 2.3000 1.7500
N 8 8 8
Std. Deviation .64550 .53541 .37859
Minimum 2.00 1.60 1.20
Maximum 3.50 2.90 2.00
Range 1.50 1.30 .80
Median 2.7500 2.3500 1.9000
Adenoma Mean 3.0000 1.8667 1.2333
N 5 5 5
Std. Deviation .50000 .49329 .37859
Minimum 2.50 1.30 .80
Maximum 3.50 2.20 1.50
Range 1.00 .90 .70
Median 3.0000 2.1000 1.4000
Cysts Mean 2.7500 2.6000 1.8500
N 8 8 8
Std. Deviation .35355 .14142 .07071
Minimum 2.50 2.50 1.80
Maximum 3.00 2.70 1.90
Range .50 .20 .10
Median 2.7500 2.6000 1.8500
Total Mean 2.8356 1.4822 1.0738
N 60 60 60
Std. Deviation 1.05876 .52105 .42833
Minimum 1.00 .90 .50
Maximum 6.00 2.90 2.00
Range 5.00 2.00 1.50
Median 2.5000 1.3000 .9000
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Table 3 Mean ADC cut off value for the differentiation between benign and malignant liver lesions at b 1000 diffusion gradient:
.
Cutoﬀ AUC± SE 95%CI Sensitivity (95%CI) Speciﬁcity (95%CI) Accuracy (95%CI) PPV (95%CI) NPV (95%CI)
ADC0 1000 6 1.0 0.895 ± 0.059 0.767–0.967 90.32% (74.2–98%) 78.57 (49.2–95.3) 86.7 (72–95.1) 90.3 (79.7–96.5) 78.6 (55–92.2)
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of all benign hepatic focal lesions were signiﬁcantly higher than
all malignant focal lesions at b 500 and b 1000 gradients
(P< 0.0001) (Figs. 3 and 4).
Differentiation of benign and malignant subtype lesions
from each other in their groups shows some promising
results. There was a statistically signiﬁcant difference
between: the mean ADC values of cysts and adenoma at
both b 500 and b 1000 (P value = 0.002, <0.001),
the mean ADC values of cysts and FNH at b 500
(P value = 0.001). However, there was no signiﬁcant differ-
ence between mean ADC values of other benign focal
lesions from each other.
At b 500 gradient, HCCs had signiﬁcant high ADC value
than metastases and cholangiocarcinoma (P value = 0.034,
0.014 respectively) with difﬁcult differentiation between metas-
tases and cholangiocarcinoma. At b 1000 gradient, there was
no signiﬁcant difference between HCCs, metastases and
cholangiocarcinomas.
There was a statistically signiﬁcant difference between
ADC values of solid benign (adenoma, FNH) and solid
malignant subtype lesions, as there was a signiﬁcant differ-
ence between: mean ADC values of FNH and HCC at
both b 500 and b 1000 (P value 6 0.001, <0.001) (Figs.
5 and 6), mean ADC values of FNH and metastases at
both b 500 and b 1000 (P value 6 0.001, 0.004) and mean
ADC values of FNH and cholangiocarcinoma at both b
500 and b 1000 (P value = 0.005, 0.015) respectively. Also,
a signiﬁcant difference was found between: mean ADC
values of adenoma and HCC at both b 500 and b 1000
(P value 6 0.001, 0.008), mean ADC values of adenoma
and metastases at both b 500 and b 1000(P value 6 0.001,
0.014) and mean ADC values of adenoma and cholangio-
carcinoma at both b 500 and b 1000 (P value 6 0.001,
0.023) respectively.4. Discussion
Reliable detection and characterization of focal liver lesions
are critical for optimal patient management. Magnetic reso-
nance imaging (MRI) has an established role in focal liver le-
sion detection and characterization and traditionally includes a
combination of unenhanced T1- and T2-weighted sequences,
in and out-of-phase T1-weighted sequences, and enhanced
T1-weighted sequences after gadolinium administration or
other liver-speciﬁc contrast agents. There is good evidence that
diffusion-weighted (DW) MRI has the potential to improve
hepatic lesion detection rates and contribute to the differenti-
ation of benign from malignant hepatic lesions (12).
Appearance of focal hepatic lesions on DWI especially at
high b values was reported to be diagnostic in several studies
due to restricted diffusion and increased signal intensity on
DW images (8,17). However this measurement was a qualita-
tive assessment and represented a subjective interpretation.
On the contrary, ADC value is a quantitative parameter of
water diffusion. There are several studies in the literature
emphasizing diagnostic utility of ADC measurement in the dif-
ferentiation of benign and malignant focal hepatic lesions.
According to these studies malignant lesions had lower ADC
values compared to benign lesions which was attributed to
high cellularity of malignant masses (7).
Chandarana and Taouli (18) said that, there is no consen-
sus in the scientiﬁc community about which b-values are opti-
mal for liver imaging and when performing DW-MRI in the
liver, it is advantageous to perform imaging with at least 3 b-
values including both lower and higher b-values (e.g. using
b= 0, b 6 100, and bP 500 s/mm2). Goshima et al. (19) rec-
ommended DW-EPIs with low and high b values as supple-
mentary sequences in the detection and characterization of
benign and malignant hepatic lesions. In our study, DWI
was done with 3 diffusion gradients at b 0, b 500 and b 1000.
Fig. 1 Diffusion weighted MR images of female patient, aged 35 years with small focal hemangioma, DWI at b0 (A), b 500 (B), b 1000
(C). ADC map at b 1000 (D) shows relative high SI with high mean ADC value = 1.7 · 103 mm2/s.
Table 4 Mean ADC cut off values for the differentiation between benign and malignant liver lesions at both b 500 and b 1000
diffusion gradients:
.
Cutoﬀ AUC± SE 95%CI Sensitivity (95%CI) Speciﬁcity (95%CI) Accuracy (95%CI) PPV (95%CI) NPV (95%CI)
ADC01000 6 1.0 0.97 ± 0.02 0.87–0.998 90.32% 92.86% 91.1 96.6 81.3
+ADC500 6 1.5 (74.2–98%) (66.1–99.8%) (77.1–95.3 (85.7–99.8) (61.5–87.2)
304 M.A. Latif et al.Most of the studies (1,20,10) indicated that a region of
interest (ROI) should be placed within the conﬁnes of the
lesion in image analysis and put away from prominent vas-
cular structures to avoid motion artifact. However, some
authors (1,20) placed ROI that covered entire lesions
without separating component with various signal intensities
for analysis of heterogeneous lesions, whereas Gourtsoyianni
et al. (10) put the ROI in both sites in a lesion with different
signal behavior in the periphery and center. In the currentstudy, ROI was placed within the conﬁnes of the lesion
and put away from vascular and necrotic portions of the
lesion.
Kandpal et al. (21) found that respiratory-triggered DWI
was superior to breath-hold DWI for hepatic imaging because
it provides higher SNR. In our study, DWI was done with the
respiratory triggered technique.
Most of the studies included hemangiomas and cysts in the
benign lesion group (7,22,23). Thus it was concluded that
Fig. 2 Diffusion weighted MR images of 60 year old male patient with HCC, DWI at b0 (A), DWI at b 500 (B), DWI at b 1000 (C) and
ADC map (D) shows restricted diffusion with mean ADC value at b 1000 = 0.85 · 103 mm2/s.
Fig. 3 Diffusion weighted MR images of 42 year old male patient with hemangioma, DWI at b0 (A), DWI at b 500 (B), DWI at b 1000
(C) and ADC map (D) shows mixed high SI with high mean ADC value at b 1000 = 2 · 103 mm2/s.
The role of MR diffusion in differentiation of malignant and benign hepatic focal lesions 305hypercellular benign lesions like FNH should also be studied
in order to discriminate benign and malignant hepatic lesions
more reliably (10). While in the study of Onur et al. (11), solid
(high cellular) benign liver lesions were included with exclusion
of cystic benign lesions. In our study, cystic benign lesions ashemangiomas and cysts and solid benign lesions as FNH
and adenoma were included in the benign lesion group.
Our results revealed that ADC measurements at b 500 and
b 1000 diffusion gradients were useful in differential diagnosis
of benign and malignant lesions and adding ADC cut off
Fig. 4 Diffusion weighted MR images of 55 year old male patient with small HCC, DWI at b0 (A), DWI at b 500 (B), DWI at b 1000 (C)
and ADC map (D) shows isointense SI with restricted diffusion with mean ADC value at b 1000 = 0.9 · 103 mm2/s.
Fig. 5 Diffusion weighted MR images of 40 year old female patient with FNH, DWI at b0 (A), DWI at b 500 (B), DWI at b 1000 (C).
ROI is located peripherally in the lesion since central part represents vascular scar tissue. Mean ADC value at b 1000
(D) = 1.3 · 103 mm2/s. Though lesion is hyperintense at DWMRI, it shows high ADC value.
306 M.A. Latif et al.values at b 500 and b 1000 diffusion gradients increases sensi-
tivity and speciﬁcity for differentiation.
In the present study, comparison of ADC values for individ-
ual benign and malignant lesions showed that there were statis-
tically signiﬁcant differences between lesions at different
gradients.MeanADC values at b 500 and b 1000 of different be-
nign lesions are as follows: FNH (1.86 and 1.46 · 103 mm2/s),adenoma (1.86 and 1.23 · 103 mm2/s), hemangioma (2.30
x103 mm2 and 1.75 · · 103 mm2/s) and cysts (2.60 · 103
mm2/s and 1.85 · 103 mm2/s). While, mean ADC values at
b 500 and b 1000 of different malignant lesions are: HCC
(1.26 and 0.89 · 103 mm2), metastases (1.11 and 0.80 ·
103 mm2) and cholangiocarcinoma (1.05 and 0.75 ·
103 mm2).
Fig. 6 Diffusion weighted MR images of 57 year old male patient with HCC, DWI at b0 (A), DWI at b 500 (B), DWI at b 1000 (C). The
lesion shows low SI on ADC map (D) with restricted diffusion and mean ADC value at b 1000 = 0.8 · 103 mm2/s .
The role of MR diffusion in differentiation of malignant and benign hepatic focal lesions 307In the study of Onur et al. (11), FNH was easily differenti-
ated from malignant lesions except HCC at b 100 gradient.
Other benign solid liver lesions also could be differentiated
from metastases and cholangiocarcinomas at all gradients.
They concluded that solid benign liver lesions did not show
a signiﬁcant difference from HCCs at all gradients. Also, Pari-
kh et al. (8) and Demir et al. (9) said that the ADC values of
these solid benign lesions were similar to ADC values of malig-
nant lesions. Yet, in our study, FNH and other benign lesions
could be differentiated from malignant lesions including HCC
at both b 500 and b 1000 diffusion gradients.
Taouli et al. (7) concluded that some overlap is present be-
tween metastatic lesions and FNHs, however, in our study,
metastatic lesions had lower ADC values than FNH at both
b 500 and b 1000 diffusion gradients. This matches with the
results of Onur et al. (11) who observed that ADC measure-
ments were successful in differentiating these lesions. This
may be due to exclusion of necrotic components of metastases
at ADC measurement which may increase the ADC values of
metastases.
In the current study, the differentiation between different
subtypes of malignant lesions with mean ADC values showed
some difﬁculty at both gradients. At b 500 gradient, HCCs had
signiﬁcant high ADC value than metastases and cholangiocar-
cinoma with difﬁcult differentiation between metastases and
cholangiocarcinoma. At b 1000 gradient, a signiﬁcant differ-
ence was only found between HCCs and cholangiocarcinomas.
This is similar to the results of Gourtsoyianni et al. (10), Kilic-
kesmez et al. (24) and Onur et al. (11) who concluded that the
differentiation of malignant lesions with mean ADC values
was difﬁcult at all gradients and similarity of ADC values
was found between malignant hepatic lesions. Onur et al.
(11) said that, the reason for highest mean ADC values mea-
sured in HCCs among all malignant lesions may be due torelatively increased perfusion of HCCs than hypovascular
metastases and cholangiocarcinomas and we agree with that
explanation.
Results of our study showed that cysts and hemangiomas
have high ADC value than adenoma and FNH, however, cysts
and hemangiomas and also adenoma and FNH could not be
differentiated well from each other at both diffusion gradients,
This is similar to the results of Onur et al. (11), as ADC mea-
surements were not helpful in differential diagnosis of different
types of solid benign lesions.
Sandrasegaran et al. (25) and Miller et al. (26) suggested
that ADC values of solid benign lesions (FNH and adenoma)
are similar to malignant lesions (metastasis and HCC) and
DW imaging is not helpful in differentiating solid benign le-
sions from solid malignant lesions. However, in our study,
there was a signiﬁcant difference between solid benign (ade-
noma, FNH) and solid malignant lesions. This may be due
to diminished perfusion effect due to high diffusion gradient
as we used b 0, b 500 and b 1000 and previous studies used b
0, b 50 and b 500 as diffusion gradients.
Different studies reported variable ADC cut-off values for
differentiation of benign and malignant focal hepatic lesions.
Taouli et al. (7) offered a threshold value as 1.5 · 103 at b
500 gradient with sensitivity of 84% and speciﬁcity of 89%.
Parikh et al. (8) reported an ADC value of 1.6 · 103 as a
cut off value with sensitivity of 74.2% and speciﬁcity of
77.3% at b 500 gradient. Onur et al. (11) concluded a cut-off
value of 1.23 · 103 at b 1000 with sensitivity of 83% and spec-
iﬁcity of 76% for differentiation between benign and malig-
nant lesions. In our study, using 1.0 · 103 mm2/s as an
ADC cut-off value at b 1000 diffusion gradient resulted in
90.3% sensitivity, 78.6% speciﬁcity and 86.7% accuracy for
differentiation of benign and malignant focal hepatic lesion
groups. The best result was obtained with the use of ADC
308 M.A. Latif et al.cut off value (at b 500) of 1.5 · 103mm2/s and ADC cut off
value (at b 1000) of 1.0 · 103mm2/s, with 90.3% sensitivity,
92.86% speciﬁcity, and 91.1% accuracy.
To best of our knowledge, there are only few studies in the
literature measuring ADC values of different subtypes of either
benign or malignant lesions. Our results showed that HCC had
high ADC value than metastases and cholangiocarcinima in
the malignant group liver masses. Cysts and hemangiomas
had high ADC values than adenoma and FNH in the benign
group liver masses.
5. Limitation of the study
There was a small number of cases with FNHs and other be-
nign liver masses and as well as cholangiocarcinoma. However,
these lesions were not seen usually as metastases or HCC and
most of these lesions (FNH, other benign liver masses and
cholangiocarcinoma) were rarely compared with each other
via ADC values in the literature.
6. Conclusion
So, adding DWI to routine abdominal MRI and ADC mea-
surements at least at 2 different gradients is a useful tool in dif-
ferential diagnosis of malignant from benign liver lesions and
may be useful for differentiation of different subtypes of either
benign and malignant lesions, further investigation in this
point is recommended.
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